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Docosahexaenoic acid (DHA) is a long-chain fatty acid essential for brain growth 
and cognitive development in infancy.  There is some evidence that DHA can also 
influence growth in infancy and early childhood.  Several clinical trials with infants and 
young children have found lower normalized growth following DHA increased exposure 
through maternal supplementation during pregnancy and/or lactation or infant formula 
supplementation.  The aim of this study was to evaluate the impact of feeding one of f ur 
concentrations of DHA in infant formula on weight-for-length percentile (<2 years) and 
body mass index (BMI-age) percentile (≥2 years) at twelve study visits from birth to four 
years of age.  Healthy formula-fed infants were randomized to one of four infant 
formulas containing 0, 0.32, 0.64, or 0.96% of total fatty acid from DHA.  Weight, 
length, and head circumference were measured at 6 weeks, 4 months, 6 months, 9 
months, 12 months, 18 months, 2 years, 2.5 years, 3 years, 3.5 years, and 4 years of age.  
Subjects were normalized to the Center for Disease Control weight-for-length (<2 years) 
and BMI-age growth charts (≥2 years) by calculating percentiles.  The relationship 
between weight-for-length and BMI-age percentiles across study visits and DHA 
concentration in the study formula were evaluated with a two way repeated measures 
ANOVA using a p-value of 0.05 as statistically significant.  The concentration of DHA 
consumed through infant formula during the first year of life did not impact weight-for-
length or BMI-age percentile from birth to 4 years of age (P =0.683).  When grouped by 
DHA or no DHA there was no statistical significance (P =0.416).  There is no observable 
difference in weight-for-length or BMI-age in infants supplemented DHA through infant 
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Acanthosis nigricans: a brown to black, velvety hyperpigmentation of the skin 
associated with insulin resistance and obesity 
Acceptable Macronutrient Distribution Range (AMDR):  the National Academy of 
Science’s recommended intake ranges for energy, carbohydrate, fiber, fat, fatty acids, 
cholesterol, protein, and amino acids developed in 2002 
Adequate Intake (AI): the amount of a nutrient that appears to sustain good health, 
developed by the Food and Nutrition Board for nutrients that have not yet received 
enough scientific study to merit setting of an official Recommended Dietary Allowance 
(RDA) 
Adipocyte: also known as lipocytes and fat cells, the cells that primarily compose 
adipose tissue and specialize in storing energy as fat 
Aminotransferase: an enzyme that catalyzes the transfer of an amino group from a 
donor molecule to a recipient molecule 
Dietary Reference Intake (DRI):  a system of nutrition recommendations to assess 
groups from the Institute of Medicine (IOM) of the US National Academy of Sciences 
intended for the general public and health professionals 
Gestational age: the age of an embryo or fetus 
Lipolysis: the breakdown of fat stored in fat cells 
Metabolic syndrome: a combination of medical disorders that increase the risk of 







Docosahexaenoic acid (DHA) is an omega-3 fatty acid essential for brain growth 
and cognitive development in infancy and is fortified in most commercial infant formula.  
There is conflicting evidence on the impact of DHA on weight-for-length in infancy and 
BMI-age in early childhood.  Animal research indicates that DHA plays a role in pre-
adipocyte proliferation and reduces adiposity (1, 2). Reduction in adipose tissue could 
translate into lower body weight with supplementation of omega-3 polyunsaturated fatty 
acids (n-3 PUFA).  Randomized controlled trials with preterm and term infants h ve 
shown lower growth indices with DHA supplementation.  Additionally, clinical tris 
with maternal supplementation of DHA during pregnancy and/or lactation have shown 
associations with growth during early childhood. 
A 2001 review of 13 randomized studies in preterm infants and 19 randomized 
studies in term infants determined that n-3 PUFA supplementation may lead to lower 
normalized growth in preterm and term infants under some experimental conditions.   
The difference appears to be minimal with limited physiological and clinica  relevance 
(3).  There is some evidence that DHA in infant formula may contribute to lower 
normalized growth in VLBW preterm infants but may be dependent on the concentration 
of DHA and other constituents in the formulas.   
In term infants few studies demonstrate a difference in growth when 
supplemented with a formula source of DHA.  One study found significantly lower mean 
weight at 4 months of age (P =0.055) with a high alpha-linolenic acid (ALA) 
supplemented formula (3.2% of fatty acids).  Infants who received the high ALA formula 




21, 40 and 120 days (4 months) of age.  The study did not find differences in growth 
before or after the 4 month assessment (4).    
Morris et al. (5) reported lower subscapular skinfold thickness in infants 
consuming formula supplemented with 0.2% DHA and 0.4% ARA compared to a 
standard unsupplemented formula.  Small but statistically significant differenc s were 
found between the two groups at 6 weeks (7.3 mm in supplement group, 7.8 mm in 
control group; P < 0.046) and at 3 months (7.6 mm in supplement group, 8.3 mm in 
control group; P < 0.012) but these differences were not evident at 6 or 12 months.  
Three clinical trials investigated the relationship between early DHA
supplementation and BMI in young children.  In all three clinical trials mothers 
consumed DHA supplements during pregnancy and/or lactation and investigators 
measured BMI in the offspring.   Only one study showed a negative association between 
maternal DHA supplementation and weight and BMI (6).  Another showed no association 
between maternal DHA supplementation and BMI (7, 8).  A third study showed a 
positive association between maternal DHA supplementation and BMI and head 
circumference (9).  
Research on infant supplementation of DHA and weight-for-length in infancy and 
BMI-age in early childhood is inconsistent.  Some studies suggest that supplementing 
DHA in infancy may lower weight-for-length and BMI-age at one or more p ints during 







Justification for Further Investigation 
 Currently there are gaps in the literature.  Although there is a good amount of 
research on DHA supplementation though infant formula on growth in infancy and there 
is growing research on maternal supplementation and BMI in early childhood there is no 
present research on DHA supplementation with infant formula that contains both DHA 
and arachidonic acid (ARA) and BMI in childhood.  The research in preterm and term 
infants is mixed with some indicating lower weight, weight-for-length, or fat m ss with 
DHA supplementation through infant formula compared to unsupplemented formula.  
Maternal DHA supplementation during pregnancy and/or lactation has resulted in a 
positive, negative, or no association to BMI in different studies at various ages during 
childhood. 
The amount of DHA supplemented though infant formula and maternal 
supplementation varies among studies.  Therefore it is desirable to examine the eff cts of 
different doses of intake.  Utilizing a sample of children supplemented with one of four 
concentrations of DHA as infants, we had an opportunity to evaluate the growth from 
birth to four years of age. One formula contained no DHA or ARA.  The other formulas 
provided 0.32, 0.64, and 0.96% of intake of total fatty acids as DHA and 0.64% ARA. 
Statement of Purpose 
 The objectives of this study were to 1) determine if the concentration of DHA 
intake consumed throughout infancy in infant formula impacts growth, particularly 
weight-for-length percentiles (< 2 years) and body mass index percentiles (≥ 2 years) 




infancy lowers weight-for-length (< 2 years) or BMI percentiles (≥ 2 years) from birth to 
4 years of age for infants receiving DHA through formula. 
Research Questions 
 Primary Questions: 
1. Is there a relationship between the concentration of DHA supplemented in 
infant formula consumed from birth to one year of age and weight-for-length 
percentiles (< 2 years) or body mass index percentiles (≥2 years) during the 
first four years of life?   
2. Does DHA and ARA supplementation during infancy lower body mass index 
at four year of age? 
 Secondary Questions: 
1. Is energy intake as determined by analysis of 24-hour dietary recalls rel ted to 
growth in the first four years of life? 
2.   Are there other maternal or infant characteristics that impact weight-for-  











Chapter 2: Review of Literature 
Normal Infant Growth 
Infants grow exponentially in the first year of life.  Although individual growth 
varies, the rate and proportion of weight gain typically follow a pattern.  Frombirth to 6 
months of age, an infant may grow 1/2 to 1 inch (about 1.5 to 2.5 centimeters) a month 
and gain 5 to 7 ounces (about 140 to 200 grams) a week. Infants typically double their 
birth weight by 5 to 6 months of age.  From 6 to 12 months of age, an infant may grow 
3/8 inch (about 1 centimeter) a month and gain 3 to 5 ounces (about 85 to 140 grams) a 
week (10).  As a result infants will double their birth height and triple their birth weight 
by 12 months of age.  During the second year, toddlers grow about 1 inch and 2 pounds 
about every 3 months. Children's growth slows considerably after age 2 years (10).   
The 2000 Center for Disease Control (CDC) Growth Charts illustrate the 
distribution of normal growth in United States infants and children.  They are used by 
health professionals such as pediatricians, nurses, dietitians, and parents to track the 
growth of infants, children, and adolescents. The 2000 revision of the growth curves were 
developed with data collected in five cross-sectional, nationally representativ  health 
examination surveys: the NHES II (1963–65) and III (1966–70), and NHANES I (1971–
74), II (1976–80), and III (1988–94) (11).   
The most recent CDC Growth Charts consist of a set of charts for infants at birth 
to 36 months of age and a set of charts for children and adolescents from 2 to 20 years of 
age.  They are gender-specific and include smoothed percentiles for weight-for-age, 




girls have slightly different growth patterns with boys tending to gain weight and height 
in infancy more rapidly than girls (12). 
The growth charts for children and adolescents include weight-for-age, stature-
for-age, and body mass index-for-age (BMI-age) curves.  The BMI-age chartswere 
added in 2000 and can be used to identify children who are overweight and obese during 
childhood.  Although BMI is calculated the same way for children and adults, the criteria 
used to interpret the meaning of BMI for children and adolescents are different. For 
children and adolescents, BMI, age, and gender-specific percentiles are used primarily 
because the amount of body fat changes during growth.  The amount of body fat also 
differs between girls and boys.  The CDC BMI-age growth charts take into account these 
differences and allow professionals to translate BMI into a percentile for a child's sex and 
age (11).   
Table 1 illustrates the categories used to indicate child weight status.  The main 
BMI categories are the same for children and adults: underweight, normal or helthy 
weight, overweight, and obese.  
TABLE 1 BMI-age categories for children 2 to 20 years 
Weight status category Percentile range 
Underweight Less than the 5th percentile 
Healthy weight 5th percentile to less than the 85th percentile 
Overweight 85th to less than the 95th percentile 






Factors that Affect Infant Growth 
There are many pre- and postnatal factors that affect birth weight and growth.  
Among these are genetic factors such as mother’s height and ethnicity; ev ronmental 
factors such as exposure to cigarette smoke and socioeconomic status.  A study 
completed at the University of Kansas Medical Center that included a number of mixed 
race children compared risk factors among three distinct growth trajectories: 1) early 
onset overweight (10.9%), defined as overweight before 2 years of age; 2) lat onse  
overweight (5.2%), defined as overweight occurring between 2 and 4 years of age; and 3) 
never overweight (83.9%) (13).   
Investigators found there were several risk factors associated with early onset 
overweight status, i.e. overweight occurring before 2 years of age.  Maternal overweight 
[BMI ≥25 and <30 kg/m2, odds ratio (OR), 2.2; 95% confidence interval (CI), 1.3 to 3.7] 
or obesity (≥30 kg/m2, OR, 5.1; 95% CI, 2.9 to 9.1), maternal weight gain during 
pregnancy (≥20.43 kg, OR, 1.7; 95% CI, 1.0 to 2.9), birth weight (≥4000 g, OR, 2.0; 95% 
CI, 1.2 to 3.4), male gender (OR, 1.5; 95% CI, 1.0 to 2.2), and black ethnicity (OR, 1.7; 
95% CI, 1.1 to 2.6) were associated with an increased risk of early onset overweight. 
These risk factors, except maternal weight gain, were also related to late onset 
overweight (13).   
In that study, maternal smoking (OR, 1.6; 95% CI, 0.8 to 3.1) was associated with 
an increased risk of late onset overweight only (4). As noted above, the mean maternal 
pre-pregnancy BMI was also a predictor of overweight.  In addition, mothers of children 
in the late onset overweight group were slightly older and had a lower level of education 




trajectory.  The mean birth weight in the early onset overweight group was gre ter than in 
the normal weight group (P <  0.01) (13).   
Differences in size and growth are observed among the major racial-ethnic groups 
in the United States related most likely to environmental factors.  Children of all major 
racial-ethnic groups have similar growth potential.  Inherited effects on growth are small 
compared with the effects of the environment, nutrition, and health.  Regardless of racial-
ethnic status, children given good nutrition, access to health care, and good social and 
overall living conditions have similar growth patterns (14-17) .   
Breast-feeding is considered the gold standard of nutrition for full-term infants 
during the first 6 months after birth and should be continued with the addition of solid 
foods through the first 12 months. The association between breast-feeding and infant 
growth has been carefully investigated.  Breast-fed infants tend to gain weight more 
rapidly in the first 2–3 months than formula-fed infants; however, from 6 to12 months 
breast-fed infants tend to weigh less than formula-fed infants (18).  The growth pattern 
associated with breastfeeding compared to formula feeding is likely due to physi logical 
differences in feeding with the breast compared to bottle and feeding patterns rather than 
to the nutrients in the diets (8).  Most studies that examined the effects of breasteeding 
versus formula feeding on body mass index after infancy have not found differences (19, 
20).  
Low Birth Weight and Infant Growth 
A significant predictor of infant growth is weight at birth.  Infants born with a low 




categorized by either weight or size.  The CDC Pregnancy Nutritional Surveillance 
System (PNSS) classifies birth weight in five categories (Table 2). 
TABLE 2  Classifications of birth weight 
PNSS indicator Birth weight 
Very Low (VLBW) <1500 g 
Moderately Low (MLBW) 1500 to <2500 g 
Low (LBW) <2500 g 
Normal (NBW) 2500-<4000 g 
High (HBW) >4000 g 
 
Within birth weight categories infants are also classified in relation to size for 
gestational age.  These classifications include small-for-gestational age, appropriate-for-
gestational age, and large-for-gestational age.  Small-for-gestational age (SGA) infants’ 
weight, length, and/or head circumference fall below the 10th percentile for gestational 
age.  Appropriate-for -gestational age (AGA) infants’ weight, length, and/or head 
circumference fall between the 10th and 90th percentiles for gestational age.  Large-for-
gestational age (LGA) infants’ weight, length, and/or head circumferenc are above the 
90th percentile for gestational age. 
Infants born small for gestational age (SGA) or born with very low birth weight 
(VLBW) tend to growth more rapidly after birth and can catch up in weight to infants 
born at a normal birth weight.  Even though these children experience catch up growth,
they may achieve a height >2 standard deviations (SD) below the mean.  Catch up growth 




Catch up growth during infancy and toddlerhood is very important because if it 
does not occur VLBW may lead to stunting.  Investigators found that children who 
remained short at 2 years of age had a high risk of short stature later in life. The risk of 
having a short final height (<-2 SD) was five times higher for children with a low birth 
weight and seven times higher for those with a low birth length in comparison with 
children with a normal birth size.  About 20% of all children of short stature were born 
SGA (22).   
Results of one study of children showed that catch up growth in weight, height, 
and BMI occurred between 8 and 20 years among VLBW females but not among VLBW 
males who remained significantly smaller than their controls at 20 yearsold (23).  
Among the VLBW males, mean weight-for-age z scores at birth, 40 weeks, and 8 years 
were -0.7, -1.8, and -0.5; and height-for-age z scores were -1.2, -2.6, and -0.5, 
respectively.  
For VLBW females at the same respective ages, mean weight-for-age z scores 
were -1.1, -2.0, and -0.2 and height-for-age z scores were -1.2, -2.4, and -0.2, 
respectively.  At 8 years of age, VLBW males had a significantly lower mean weight, 
height, and BMI than normal birth weight (NBW) controls, whereas VLBW females 
differed significantly from their NBW controls in mean weight and BMI but not i  height 
(23).   
Catch up growth may lead to normalized stature in children, particularly females.  
Weight and BMI may take longer to reach the normal distribution (50th percentile) during 
childhood, but they may continue to increase after linear growth slows and lead to 




during infancy may substantially increase individuals’ risk of obesity later in life.  A 
2006 review concluded that rapid prolonged catch up growth may lead to excessive 
weight gain in subsequent years (24). In both preterm and term LBW infants rapid 
growth compared to normal growth increases the risk of later obesity.  A systematic 
review found that the odds ratio (OR) for obesity with rapid growth ranged from 1.17 to 
5.70 (25).   
Rapid weight gain is associated with high body mass index z scores in later ye rs 
even when an infant is born with a low weight-for-length.  Ong et al. (26) found children 
who showed catch up in weight or length between birth and two years were heavier and 
taller than other children at five years and were also taller in relation to their mothers' 
heights (0.15±1.01, paired t test: P < 0.0005) and fathers' heights (0.05±0.92, P <
0.0005). These children had greater body mass index, total fat mass, percentage body fat,
and central fat distribution (26).  
Hui et al. (27) found rapid catch up growth from birth to 3 months in infants born 
with low birth weight (mean birth weight of 2.8 kg) which had a larger effect on the BMI 
z scores in boys (mean difference, 0.88; 95% CI, 0.69-1.07) than in girls (mean 
difference, 0.52; 95% CI, 0.33-0.71). With each unit increase in the weight z score at 
ages 0 to 3 and 3 to 12 months increased the BMI-age z score by 0.52 and 0.33, 
respectively (27). 
A New York State cohort of parents/guardians of children participating in the 
Special Supplemental Nutrition Program for Women, Infants, and Children (WIC) found 
that ethnicity and rapid gains in weight-for-length in the first 6 months of life were 




Hispanic, 19% black, and 49% white.  The odds of being overweight at 4 years of age for 
Hispanic children were twice that of non-Hispanic children (odds ratio, 2.2; 95% 
confidence interval, 1.5 to 3.3). The risk of overweight at 4 years of age was 19% for 
children in the highest quintile of infant weight gain in this WIC population (28). 
High Birth Weight and Infant Growth 
High birth weight is also important to recognize because it is associated with 
obesity in later years.  More than two dozen studies have addressed the association 
between high birth weight and later obesity [for review see (25)].  Almost all found that 
higher birth weight was associated with higher attained BMI in childhood and adulthood.  
In the 2005 metaanalysis, 18 studies assessed the relationship between infant size nd
obesity later in life.  Most studies showed that infants who were at the highest end of the 
distribution for weight or weight for length had an increased risk of obesity. When 
compared with non-obese infants, those who had been obese had a relative risks for 
subsequent obesity of 1.35 to 9.38 (25).  
In a 2009 study of 559 children, infants in the highest quartile of birth weight-for-
length z scores compared with those in the lowest quartile had higher BMI-age z scores at 
3 years of age (β= 0.51; 95% confidence interval, 0.28–0.75) (29).  This recent study 
confirmed that infants with higher relative weight-for-length at birth have a greater risk 
of obesity in older years. In Hong Kong a study of 6,075 term births (77.5% successful 
follow-up) found an association between high birth weight, growth rate, and BMI at 7 
years of age.  Children in the highest birth weight and growth rate percentiles had the 





Childhood Overweight Status 
Childhood overweight status is a growing problem in the United States with 11-
17% of children and adolescents ages 2 through 19 years at or above the 95th percentile 
(obese) and 32% at or above the 85th for weight (overweight) (30, 31).  Children who are 
overweight are more likely to be overweight as adults.   Krassas et al. (32) observed that 
over 80% of obese children reported being obese adults.   
Research indicates that a child’s body mass index is predictive of overweight 
status later in life.  Nader et al. (33) showed that 2 in 5 children whose BMIs were ≥50th 
percentile during the preschool period (2, 3, and 4.5 years of age) were overweight at 12 
years of age.   Additionally, children who were overweight (<85th percentile) during the 
preschool period were >5 times more likely to be overweight at 12 as those who were not 
overweight at any of the three preschool ages.   
Overweight status in children is important to monitor because it is associated with 
significant health problems.  Disease risk factors can develop during childhood and 
persist throughout adolescents and adulthood.  Bell et al. (34) reported a positive 
relationship between increasing BMI-age z scores and components of metabolic 
syndrome including blood pressure, fasting insulin levels, presence of acanthosis 
nigricans, and elevated aminotransferase levels.  Investigators also found an association 
with high density lipoprotein (HDL) cholesterol and triglyceride levels indicating that 
high BMI-age z scores have an impact on unfavorable lipid profiles (34).  
There are many contributing factors to childhood overweight status.  Some 
lifestyle and environmental factors in children are defined include inactivity, high intake 




heavy marketing of energy-dense foods and fast food restaurants, adverse socioecon mic 
conditions, and large portion sizes (35).  Due to the growing childhood obesity epidemic 
and large number of contributing factors, there is a need to decrease obeseogenic factors 
and increase factors that inversely affect weight. 
Docosahexaenoic Acid  
Docosahexaenoic acid (DHA) is a long-chain omega-3 polyunsaturated fatty acid 
(n-3 LC-PUFA) essential for brain growth and cognitive development.  DHA is essential 
for optimal visual and neurological development during infancy and toddler years.  It has 
been studied both pre- and post-natally in many clinical trials around the world [for 
reviews see (36) and (37)].  Eicosapentaenoic acid (EPA) is an omega-3 fatty acid 
precursor for DHA. 
Human brain and retinal tissue are naturally concentrated with DHA.  It makes up 
40% of the PUFAs in the brain and 60% of the PUFAs in the retina (38).  Some of the 
functions of DHA include structure, cellular signaling, and gene regulation.  DHA plays a 
role in cellular signaling due to its presence in cellular membranes (39).  PUFAs are 
important components of the phospholipids in membranes and reflect dietary fatty acid 
intake.  A diet rich in DHA results in a higher concentration in membranes and influences 
physiological functions.  Many effects of LC-PUFAs depend on the formation of their 
active metabolites, eicosanoids, and other lipid mediators (40).  Eicosanoids are signaling 
molecules that have an anti-inflammatory effect when derived from omega-3 fatty acids 
(41). 
DHA plays a role in fatty acid oxidation and metabolism.  In experiments using 




preadipocytes.  DHA also increased rate of lipolysis compared with the control group 
(42, 43).  Recent research indicated that DHA plays a role in inhibition of fat cell 
proliferation and reduces adiposity in mice (1, 44).  A reduction in adipose tissue could 
translate into lower body weight and lower BMI with high omega-3 fatty acid intake. 
Dietary DHA Intake 
Fat is a significant macronutrient in the diets of infants and young children.  The 
Institute of Medicine recommends an Adequate Intake (AI) of 31 grams of fat per day in 
infants from birth to 6 months and 30 grams per day from 6 to 12 months.  The Dietary 
Reference Intake (DRI) for children 1 to 3 years of age is 30% to 40% of total energy 
from dietary fat and <10% of energy from saturated fat.    
Recommended AIs for omega-3 fatty acids are 0.5 g for infants, 0.7 g for children 
1-3 years, and 0.9 g for children 4-6 years.  This amount is based on an intake that 
“supports normal growth and neural development and results in no nutrient deficiency” 
(Food and Nutrition Board, 2004).  Although there is no DRI for EPA and DHA, the 
National Academies have recommended that approximately 10% of the Acceptable 
Macronutrient Distribution Range (AMDR) for essential fatty acids can be consumed as 
EPA and/or DHA (45).  The current mean intake of EPA and DHA by adults in the 
United States is 80-100 mg/day, which is much lower than what many groups worldwide 
are currently recommending (46).  
The Technical Committee on Dietary Lipids of the International Life Sci nces 
Institute North America sponsored a workshop June 4-5, 2008 to reconsider the DRI for 
EPA and DHA based on evidence specific to the major chronic diseases in the United 




workshop participants concluded that research demonstrates a clear, inverse relation 
between EPA and DHA intake and risk of major chronic diseases.  Current evidence 
supports a DRI for EPA and DHA between 250 and 500 mg per day for adults (46).   
Most United States infants receive DHA from either mother’s milk or DHA 
supplemented infant formula during the first year of life.  The amount of DHA in human 
milk is dependent on the mother’s dietary and supplemental intake of DHA and is highly 
variable (47).  Data from NHANES (1999-2000) indicate US children less than six years 
of age typically consume only about 20 mg/day of  DHA (48).   
A 2008 review of LC-PUFAs in pregnancy, lactation, and infancy by an 
international expert committee concluded that pregnant and lactating women should aim 
to achieve an average daily intake of at least 200 mg DHA (49).  For healthy term infants 
breastfeeding is the preferred source of nutrition; however, if breastfeeding is not 
possible infants’ should consume a formula that contains DHA at levels between 0.2 and 
0.5 % weight of total fatty acids, and with the minimum amount of arachidonic acid 
(ARA) equivalent to the contents of DHA (49, 50).  Arachidonic acid (ARA) is important 
in infant growth because ARA conditional deficiency, usually from low omega-6 intake, 
can retard growth in preterm infants (51).  Linoleic acid (LA) is an essential omega-6 
fatty acid and precursor for ARA.   
DHA and Infant Growth  
Randomized clinical trials with preterm and term infants have shown lower 
growth indices with DHA supplementation through infant formula.  A 2001 review of 13 
randomized studies in preterm infants and 19 randomized studies in term infants 




infants, particularly preterm, under some experimental conditions (3).  A Fleith and 
Clandinin (52) review in 2005 suggests the body of literature on PUFAs for preterm and 
term infants shows improved growth and development of infants; however, growth 
indices should include composition changes such as lean versus fat mass.  The following 
studies looked at differences in infants’ weight, weight-for-length, and/or body 
composition with supplementation of PUFAs compared to unsupplemented formula. 
One of the earliest studies with omega-3 PUFA supplementation for very low 
birth weight (VLBW) preterm infants showed lower head circumference and weight at all 
measurement times (2,4,6.5,9 and 12 months past expected term) with fish oil (0.2% 
DHA, 0.3% EPA) supplementation for 11 months (53).  Another VLBW preterm study 
with a low-EPA fish oil (0.25% DHA, 0.06% EPA) formula found lower weight-for-
length indices at 2, 6, 9, and 12 months past expected term in the group fed fish oil 
compared to a typical formula that contained alpha-linolenic acid (54).    However, in 
these studies lower growth indices were possibly due to a reduction in arachidoni  acid 
(ARA) levels that occurs when long chain omega-3 fatty acid supplements ar  used 
without an arachidonic acid supplement.   
Birch et al. (55) found no difference in growth parameters between VLBW 
preterm infants fed a fish-oil formula (0.35% DHA, 0.65% EPA) compared to two other 
formulas (corn-oil or soy-oil based).  Woltil et al. (56) supplemented LBW infants with 
gamma-linolenic acid (GLA), an essential omega-6 fatty acid, from evening primrose oil 
and either a high or low does of high-EPA fish oil (0.43% DHA and 0.34% EPA or 
0.20% DHA and 0.17% EPA ).  Investigators analyzed weight, length, and head 




growth rate was associated with fatty acid composition of the formula.  Brain-weight gain 
was greater in appropriate for gestational age (AGA) preterm infants fed LC-PUFAs.   
Another study with 3 groups of preterm infants fed formula with low-EPA fish oil 
and blackcurrant-seed oil (1.2 % ALA, 0.6% DHA, 0.1% EPA, and 0.1% ARA), a 
standard formula (1.3% ALA), or human milk found a positive association between LC-
PUFA supplementation and growth.  The infants had an average birth weight of 1750 
grams which is considered moderately low birth weight.  The group consuming the 
supplemented formula had greater weight gain and had a higher formula intake (57).   
Fewtrell et al. (58) compared the growth of infants receiving supplemented 
formula containing 0.17% DHA, 0.31% ARA, and 0.04% EPA to a control without 
DHA, ARA, or EPA.  Measurements were taken at 9 months and 18 months of age.  At 9 
months infants who had received LC-PUFA supplemented formula weighed 310 g less 
(95% CI: -6 to 620 g) and were shorter by 0.86 cm (-0.06 to1.78) than control infants. At 
18 months, infants fed the LC-PUFA supplemented formula weighed 370 g less (95% CI, 
12 to 735;P = .04) and were shorter by 1.5 cm (95% CI, 0.52.4;P =.004) than control 
infants. The difference in weight and length between formula groups was present in both 
males and females.  In males the weight difference was -211 g (95% CI, -337 to 759) and 
the length difference was -1.05 cm (95% CI, -0.55 to 2.64); while in females the weight
difference was -438 g (95% CI, -31 to 907) and the length difference was -1.70 cm (95% 
CI, 0.48 to 2.91).  
To adjust for gender differences between groups, investigators reported weight
and length as standard deviation (SD) scores. They showed mild reductions in length 




and weight z scores at 18 months with LC-PUFA supplemented formula.  Investigator 
observed no other significant differences in growth across visits using SD scores.  
In a 2005 study of body composition in VLBW premature infants, subjects were 
fed one of two formulas with different sources of DHA and ARA or a control formula 
with no added DHA or ARA to 12 months.  Both experimental formulas contained 0.26% 
DHA and 0.42% ARA.  One derived PUFAs from fungal oil and fish oil and the other 
formula was made from egg-derived triglyceride and fish oil.   There were no significant 
differences among the three study groups in weight, length, or head circumference at any 
of the age points; however, there were differences in body composition at 12 months 
following consumption of DHA and ARA supplemented formulas compared with the 
infants who were fed the unsupplemented control formulas.  The mean lean body mass 
was greater for infants in the DHA and ARA groups (6.83 ± 0.13 and 7.00 ± 0.14) 
compared to the control group (6.53 ± 0.15).  Average fat mass was less  for infants in the 
DHA and ARA groups (2.60 ± 0.12 and 2.60 ± 0.13)  than in the control group (3.07 ± 
0.14; P <  0.05) (59).  
There is some evidence that DHA in infant formula may contribute to growth in 
LBW preterm infants but may be dependent on the concentration of DHA, amount of 
formula intake, and other constituents in the formulas.  The latest Cochrane review 
indicated that formula supplemented with LC-PUFAs in preterm infants has no clear 
benefit or harm to infant growth, established by the pooled results of 13 random 
controlled trials.  However, the 2008 review found that a “meta-analysis of five studi 
(Uauy 1990; Carlson 1996; Hansen 1997; Vanderhoof 1999; Innis 2002) showed 




analysis of four studies at 12 months (n = 271) and two studies at 18 months (n = 396) 
post-term showed no significant effect of supplementation on weight, length or head 
circumference” (60). 
In term infants fewer studies demonstrate differences in growth when given 
formula supplemented with DHA compared to unsupplemented formula.  Lapillonne and 
Carlson (3) reviewed 7 of 19  studies with sufficient statistical power and concluded no 
difference in weight or length for term infants no matter the source of supplement d 
DHA.   
One study; however, reported lower head circumference at 4 months with formula 
containing 0.45% DHA and low-EPA fish oil compared to control formula without DHA.  
The head circumference in the supplemented group was similar to the referenc 
breastfeeding group (61).  Another study found significantly lower mean weight at 4 
months of age (P =0.055) with a high alpha-linolenic acid (ALA) supplemented formula 
(3.2% of fatty acids).  Infants who received the high ALA formula had higher plasma 
concentrations of DHA but lower concentrations of arachidonic acid at 21, 40 and 120 
days (4 months) of age.  The study did not find differences in growth before or after the 4 
month assessment (4).  
A large study (n =294) found greater weight gain for males from enrollment to 4 
months in the group fed formula containing fish oil and fungal oil (0.13% DHA and 
≤0.04 EPA) compared to the control group (31.4 ± 4.6 g/d and 27.8 ± 4.2, respectively; P 
<  0.05).  No other differences in weight, length, or head circumference were found at 1, 
2, 6, 9, or 12 months (62).  Morris et al. (5) reported lower subscapular skinfold thickness 




compared to a standard unsupplemented formula.  Small but statistically significant 
differences were found between the two groups at 6 weeks (7.3 mm in supplement group, 
7.8 mm in control group; P < 0.046) and at 3 months (7.6 mm in supplement group, 8.3 
mm in control group; P < 0.012) but these differences were not evident at 6 or 12 months.  
The 2008 Cochrane review of PUFA supplementation in term infants concluded 
that there is no identifiable physical growth benefit or harm during infancy with PUFA 
supplementation no matter the growth measure, specific type, or amount of PUFAs in 
formula (63).  Research on infant supplementation of DHA and growth in infancy and 
early childhood is inconsistent.  Few studies suggest that supplementing DHA in infancy 
may lower weight indices at one or more points during infancy.   
DHA and BMI in Children 
There are a small number of clinical trials that evaluated the relationship between 
DHA intake through maternal supplementation during pregnancy and/or lactation and 
BMI during childhood and results are inconsistent.  Helland et al. (7, 8, 64) supplemented 
pregnant and lactating women with 10 ml of either cold liver oil or corn oil from 18 
weeks of pregnancy until 3 months after delivery.  The cod liver oil contained 
approximately 1200 mg DHA and 800 mg EPA per daily serving.  Investigators found no 
significant effect of omega-3 supplementation on infant growth or on BMI at 4 and 7 year
follow-ups.  However, ALA content in breast milk correlated positively with BMI.  This 
is contrary to what investigators report in animal research (1, 44).  The study was 
conducted in Norway and was the first published report of children subjected to higher 
DHA exposure in utero who were followed long term (>18 months).  A total of 341 




A randomized controlled trial done in Germany compared longitudinal growth in 
infants whose mothers received supplementation during pregnancy and lactation.  There 
were three different supplement groups including vitamins and minerals only (basic 
supplementation), basic supplementation and probiotics, and basic supplementation, 
probiotics, and 200 mg DHA from fish oil.   Investigators found that maternal DHA 
supplementation during pregnancy lowered weight and BMI at 21 months of age.  There 
were no differences in length.  The mean weight of the DHA group was lower by 601 g 
(95% CI, – 171; - 1030g) and BMI was lower by 0.76 kg/m2 (95% CI, -0.07; -1.46) 
compared to children at 21 months of age whose mothers did not receive DHA.  Only 69 
of 144 subjects were available at 21 months (6). 
Lauritzen et al. (9) studying children in Denmark reported omega-3 intake of 
lactating mothers in a fish oil supplement group compared with a placebo group given 
olive oil resulted in higher BMI (0.06 kg/m2;P =0.022) and larger head circumference 
(0.5±0.2 cm) at 2.5 years of age in the offspring.  Weight and length did not differ 
between groups.  BMI, waist circumference, and percentage of body fat were positively 
associated with maternal red blood cell DHA content at the end of the 4 month 
intervention (r=0.238, P =0.021; r=0.301 ,P =0.007; and r=0.264, P =0.035, 
respectively).    
The women received 4500 mg/day of a fish oil that provided 800 mg DHA, 600 
mg EPA or an equivalent amount of fat from olive oil in a daily supplement for 4 months 
of lactation.  Subjects were required to have had a fish intake below the median 




higher ratio of males to females in the fish oil group (37:25) compared to the olive oil 
group (28:32).  At the 2.5 year follow-up 105 out of 150 completed the BMI assessment. 
Research on maternal supplementation of DHA and BMI in late infancy and early 
childhood is sparse. Only one study showed a negative association between maternal 
DHA supplementation and weight and BMI at 21 months of age.  Another showed no 
association between maternal DHA supplementation and BMI at 4 and 7 years of age.  A 
third study showed a positive association between maternal DHA supplementation and 
BMI and head circumference at 2.5 years of age.    
There are significant differences in supplementation source and amount, study 
design, timing, and baseline seafood intake in each geographic location among studies.  
In addition, ARA intake varies.  The effect of direct infant supplementation of DHA
through infant formula on BMI during childhood remains unclear.  Preliminary research 
shows that supplementing DHA in infancy may affect BMI.  Analyzing the impact of 
DHA from infant formula in four different concentrations will help to determine the 











Chapter 3: Methods 
 This is an observational study of infants who participated in a double-blinded, 
randomized, controlled, parallel-group trial, known as the DIAMOND Study (DHA 
Intake And Measurement Of Neural Development). The primary objective of the 
DIAMOND Study was to determine the effect of infant formula with four different 
concentrations of DHA supplementation on visual acuity of formula-fed infants measured 
at one year of age.  The formula concentrations studied were 0.0% fatty acids from DHA,  
0.32% fatty acids from DHA (17 mg/100 kcal), 0.64% DHA (34 mg/100 kcal), and 
0.96% DHA (51 mg/100kcal).   The DHA containing formulas all provided 0.64% 
arachidonic acid (ARA). 
The DIAMOND Study was conducted at two clinical sites. It was designed to a) 
determine if DHA supplementation in formula during infancy impacts the development 
of body mass index from birth to 4 years of age b) to determine the amount of DHA 
supplementation required to effect on body mass index.  All subjects reported to the 
University of Kansas Medical Center Infant Nutrition Clinic for parent-study 
appointments at 6 weeks, 4 months, 6 months, 9 months, 1 year, 1.5 years, 2 years, 2.5 
years, 3 years, 3.5 years, and at 4 years of age.  Anthropometric data, descriptiv  data, 
and 24-hour dietary recalls were obtained at each of these 11 study appointments.  
Ethics 
 This study was approved from the Human Subjects Committee as part of the 
parent trial entitled “The DIAMOND Study: A Double Masked, Randomized Controlled 




Level of Docosahexaenoic Acid” (HSC#9198 and 10205).  Infants’ parents or guardians 
were provided written informed consent prior to study participation. 
Subject Selection 
 Subject selection was according to inclusion and exclusion criteria of the parent 
study.  The infants included healthy, term (37-42 weeks gestation; 2490-4200 grams birth 
weight), formula-fed, singleton-birth infants born between September 3, 2003 and 
September 25, 2005 in the Kansas City metropolitan area.  Exclusion criteria were infants 
receiving human milk within 24 hours of randomization and diseases or congenital 
abnormalities likely to interfere with growth, development, vision maturation or cognitive 
function, poor formula intake, or intolerance to cow’s milk infant formula.  Infants born 
to mothers with chronic illnesses such as HIV, renal or hepatic disease, diabetes, or 
substance abuse were also excluded. 
Randomization to Infant Formula 
 All of the formulas were cow’s milk-based formulas with the same micronut ients 
and macronutrient levels and ingredients except for the long-chain polyunsaturated fatty 
acids (LCPUFAs).  The DHA and ARA sources were single-cell algal nd fungal oils 
from Martek Biosciences in Columbia, MD.  All DHA supplemented formulas contained 
0.64% (34 mg/100 kcal) from arachidonic acid (ARA).  The control formula did not 
contain DHA or ARA, the first level of DHA supplementation contained 0.32% fatty 
acids from DHA (17 mg/100 kcal), the second level contained 0.64% DHA (34 mg/100 
kcal), and the third level contained 0.96% DHA (51 mg/100kcal).  Other major fatty 




fatty acids linoleic acid (16.9-17.5% fatty acids) and alpha-linolenic acid (1.61-1.98% 
fatty acids).   
 Subject randomization was generated using random-number generator function 
with separation between males and females.  Randomization was performed by the study 
sponsor, Mead Johnson & Co, Evansville, IN.  Study formulas were designated by codes, 
each formula with two different codes (separating male and female) for a total of 8 codes.  
Using the randomized lists, envelopes were labeled with consecutive numbers for 
subjects containing the code of the study formula that was to be assigned.  Once enrolled
in the study, the next sequential numbered envelope of the appropriate gender was 
opened at the study site to designate which formula the infant would consume.  Formula 
(packaged by the study sponsor and only identifiable by its code) was directly provided 
for the infant at the study site.  All study personnel (directly or indirectly involved) were 
masked to which formula the infants received.   
 Infants were fed the designated formula for the 12 months of life.  The study 
formula was to be the sole source of nutrition until about 4 months of age at which time 
additional foods could be introduced as instructed by the infants’ physicians.  DHA 
supplemented or enriched foods were to be avoided until 12 months of age. 
Data Collection 
Anthropometric Data 
 Anthropometric data were obtained in the first nine days of life including birth 
weight, length and head circumference.  Longitudinal anthropometric data were collected 
at each of the infant clinic visits at 6 weeks, 4 months, 6 months, 9 months, 1 year, 1.5 




B for sample data collection forms). The technique used for the collection of each 
anthropometric data is as follows: 
a. Body weight – Subjects were weighed one time on a standard 
calibrated pediatric scale to the nearest gram by standard methods with 
dry diapers. 
b. Body length/height – Until they were 2 years of age, subjects were 
measured recumbent on a length board after positioning the head at the 
top of the board and legs held straight measuring to the nearest tenth of 
a centimeter. From 2.5 to 4 years of age, height was measured with a 
stadiometer. 
c. Head circumference – Flexible, non-stretchable measuring tape was 
wrapped snuggly around each subject’s forehead measuring the full 
circumference of the head to the nearest tenth of a centimeter. 
d. Center for Disease Control percentiles were calculated for weight-age, 
length-age, head circumference-age, and weight-for-length (<2 years) 
and BMI-age (≥2 years) using Growth BP Software for all visits.  
Formula Intake Data 
Formula intake and tolerance were assessed and collected from the parent(s) o  
caregiver(s) at each study visit.  Descriptions of the infants’ stools were obtained by the 
parent(s) or caregivers(s) including number, color, and consistency for one day.  Also any 
occurrence of constipation or diarrhea, signs of excess gas, or unusual fussiness were 





Dietary Intake Data 
Twenty-four dietary hour recalls were collected from the parent(s) or caregive (s) 
of study subjects by trained registered dietitians during study visits at 6 weeks, 4 months, 
6 months, 9 months, 1 year, 1.5 years, 2 years, 2.5 years, 3 years, 3.5 years, and at 4 years
of age.  All food and beverages consumed the day prior to coming in were captured 
including times, portion sizes, brand names and ingredients added in preparation.  A 
multiple pass method was used with the following three steps: 1) quick list, 2) detaile  
description including portion sizes and amount consumed, and 3) review of the record 
probing for missing foods and beverages.  The serving sizes were estimated using 
descriptions and a kit containing measuring tools.   Tools included measuring cups and 
spoons, pre-portioned bean bags of differing amounts, and labeled utensils with reference 
charts.  See Appendix C for the 24-hour dietary recall form. 
The dietary information from each visit was entered into the Nutrition Data 
System for Research (NDS-R) software program (v4.06_34 University of Minnesota, 
Minneapolis, MN) by trained research staff.  Dietary intakes were uploaded into the 2008 
version of NCS-R, calorie intakes were outputted, and transferred to an Excel spreadsheet 
to be entered into Statistical Package for the Social Sciences (SPSS).  Twenty-four-hour 
dietary recalls with missing meals and total calorie intakes greater th n 200 kcals/kg or 
less than 40 kcals/kg were excluded.  See Appendix D for a list of excluded dietary 
recalls.  The remaining calorie intakes for subjects grouped by formula were averaged for 
each visit (6 weeks, 4 months, 6 months, 9 months, 1 year, 1.5 years, 2 years, 2.5 years, 3 





Collection and Analysis of Data 
Data collection included each subject’s formula code, weight, length, head 
circumference,  and calorie intake for each of the visits: 6 weeks, 4 months, 6 months, 9 
months, 1 year, 1.5 years, 2 years, 2.5 years, 3 years, 3.5 years and at 4 years of ag .  The 
mother’s height and smoking status were obtained by interview.   
The data were entered into an Excel spreadsheet and transferred into SPSS.  The 
relationship between weight-for-length percentiles for birth to 18 months and BMI-age 
percentiles for 2 to 4 years and the DHA concentration in the subject’s formula were 
evaluated with repeated measures analysis of variance (ANOVA) with correcti n for 
potentially influential variables observed in the study.  The repeated measures ANOVA 
enhances the power of the study because it’s within subjects design allows the subjects to 
function as their own control.  Potential covariance included mother’s smoking status 
during pregnancy, mother’s weight, and ethnicity.  Additionally, the average calorie 












Chapter 4: Results  
The objective of the study was to 1) determine the concentration of DHA intake 
during infancy consumed through infant formula that impacts weight-for-length 
percentiles (< 2 years) and body mass index percentiles (≥ 2 years) during the first four 
years of life and 2) to determine if DHA supplementation during infancy lowers weight-
for-length (< 2 years) or BMI percentiles (≥ 2 years) from birth to 4 years of age for 
infants receiving DHA through formula. 
The total number of subjects enrolled in the original study was 159.  A subset of 
77 subjects was seen through 4 years of age and was used to generate summary statistics 
and simple correlations.  There were 3 subjects that missed 2 or more consecutive visits 
and 8 subjects that missed 1 visit from 6 weeks to 4 years of age.  Subjects that missed 
one visit were kept in the analysis.  Means were calculated for their weigh and length
from visit measures before and after the missing age.  There were 74 complete data sets 
included in the final analyses.   
 Subjects were randomized to one of four formula groups.  Formula Group 1 
contained no DHA or ARA, Formula Group 2 had 0.32% DHA, Formula Group 3 had 
0.64% DHA, and Formula Group 4 had 0.96% of total fatty acids in the infant formula 
from DHA.  Formula Groups 2, 3 and 4 had 0.64% of total fatty acids in the infant 
formula from ARA.  There were only slight differences in the number of subjects per 
formula group at 4 years (n = 16, 19, 17, 22).  The smallest number of subjects was in the 
control group and the largest number of subjects was in the formula group with the 




Characteristics were distributed evenly across formula groups.  See Table 3 for 
characteristics of the subset seen through 4 years in comparison to the original study 
population.  Table 4 shows the mean calorie intakes and Table 5 shows calories per 
kilogram across ages separated by group.  Calories and calories per kilogram were 
generated from 24-hour dietary recalls and weights taken at study visits.  Calories were 
















TABLE 3 Characteristics of the subset in comparison with the original study population  
Characteristics 
Subset study population 
(n = 77) 
Original study population  
(n = 169) 
Maternal   
    Weight at delivery (kg) 73.5 ± 39.4 69.7 ± 18.4 
    Height (cm) 163.5 ± 7.4 163.8 ± 7.0 
    Age at delivery (y) 23.4 ± 4.4 23.7 ± 5.7 
    Education level (y) 12.0 ± 1.4 12.0 ± 1.6 
    Smoking before pregnancy [n(%)] 35 (46.7%) 63 (42.9%) 
    Pack Years (PPD*years smoked) 2.1 ± 4.0 1.9 ± 3.8 
    Ethnicity   
       African American [n(%)] 51 (66%) 98 (61.6%) 
       Caucasian [n(%)] 19 (24%) 50 (31.4%) 
       Hispanic [n(%)] 5 (7%) 9 (5.7%) 
       Other [n(%)] 2 (3%) 2 (1.3%) 
Infant   
   Female [n(%)] 49 (64%) 84 (52.8%) 
   Male [n(%)] 28 (36%) 75 (47.2%) 
   Weight at birth (g) 3401.8 ± 350.4 3392.2 ± 377.2 
   Length at birth (cm) 50.0 ± 1.6 50.2 ± 1.9 
   Head circumference at birth (cm) 34.2 ± 1.3 34.2 ± 1.3 








































1 634 757 867 1051 1181 1415 1524 1510 1673 
2 660 773 845 905 1056 1488 1634 1748 1730 
3 605 703 817 994 1170 1295 1512 1586 1528 
4 632 701 853 915 1057 1192 1421 1442 1529 
Mean 
























1 133 116 107 116 125 130 128 107 104 
2 139 113 108 100 106 128 124 116 96 
3 125 106 109 110 121 110 116 102 91 
4 129 101 109 101 105 104 112 96 91 
Mean 











Two-tailed Pearson correlations for maternal weight and age at delivery as well as 
maternal height, pack years prior to pregnancy, highest attained education level, and 
infant weight-for-length/BMI-age percentiles at 12 ages (birth, 6 weeks, 4 months, 6 
months, 9 months, 1 year, 1.5 years, 2 years, 2.5 years, 3 years, 3.5 years and at 4 years) 
were obtained by using SPSS.  Maternal smoking in pack years was negatively relat d to 
birth weight-for-length percentile (P < 0.05).  Maternal age at delivery was positively 
related to birth (P < 0.01) and 6 week (P < 0.05) weight-for-length percentile.  Younger 
mothers had smaller infants than older mothers in this study population.   
Maternal weight in pounds at delivery was positively related to weight-for-length 
percentile at 18 months and BMI-age percentile at 3, 3.5, and 4 years of age (P < 0.05).  
See Table 6 for correlation values.  Mother’s weight is often positively related to infant 
birth weight; although we did not find this in our study population we did find that 
heavier mothers raised heavier children, observed at 18 months of age and at 3 years and 
older.   
There were no significant correlations between maternal height or education level 










TABLE 6 Correlations for maternal characteristics and infant weight-for-length/BMI-age 
percentile across age 
    Weight-for-length/BMI-age percentile:     


















pack years  








.300** .268* .067 -.086 .215 .033 .055 .084 
* P < 0.05 level 







DHA and Weight-for-Length/BMI-age Percentile 
Weight-for-length/BMI-age percentile was entered into age (12) and formula 
group (4) repeated measures analysis of variance (ANOVA) with maternal age nd 
weight at delivery and pack years as covariates.  We chose covariates based on Pearson 
correlations and controlled for those that had significant associations with weigt-for-
length or BMI-age percentiles.  There were no significant main effects for age and 
formula group (P =0.683).  The observed power was 0.147 with 16 subjects in Formula 
Group 1, 19 subjects in Formula Group 2, 17 subjects in Formula Group 3 and 22 
subjects in Formula Group 4.  There was no significant interaction between formula 
groups.  Mean weight-for-length/BMI-age percentiles for each formula group followed a 
similar trajectory across age with no apparent effect from DHA concentratio  consumed 
through infant formula.  Figure 1 illustrates weight-for-length/BMI-age percentiles across 
























   







FIGURE 1 Weight-for-length/BMI-age percentiles from birth to 4 years by formula 
group.  Formula Group 1 contained no DHA, Formula Group 2 contained 0.32% DHA, 
Formula Group 3 contained 0.64% DHA, and Formula Group 4 contained 0.96% DHA.  
 
After finding no significance between the 4 formula groups separated by 
concentration of DHA and weight-for-length/BMI-age percentiles, we explored the 
absence versus the presence of DHA and weight-for-length/BMI-age percentil s.  New 
DHA groups were separated by no DHA or ARA (n =16) and exposure to DHA (n =58; 
0.32. 0.64, or 0.96% DHA) and ARA (0.64%) in infant formula.  Similar repeated 
measures ANOVA with weight-for-length/BMI-age percentiles entered into age (12) and 
DHA group (2) with maternal age and weight at delivery and pack years as covariates 
and had no significant main effects for age and DHA group (P =0.416) and interaction 
between these terms was not significant.  The observed power was 0.127.  Results are 




birth to 4 years of age in infants who consumed DHA and ARA in infant formula and 
those who did not. 
























FIGURE 2 Growth percentiles from birth to 4 years with or without DHA 
supplementation.  DHA Group 1 (n =16) consumed formula with no DHA compared to 
DHA Group 2 (n =58) which were supplemented with DHA (0.34, 0.64, or 0.96% DHA). 
 
The mean BMI-age percentile for the study population at 4 years of age was at the 
70th percentile.  Thirty-nine percent of the children were overweight or obese (≤85th
percentile) at 4 years of age.   
Maternal Smoking and Weight-for-Length/BMI-age Percentile  
As a result of finding a significant negative association between maternal pack 
years and birth weight-for-length percentile and having a population with a high 
percentage of mothers who smoked and growth data of offspring to 4 years of age we 




entered into age (12) and maternal smoking status (2) repeated measures ANOVA with 
maternal pack years as a covariate had significant main effects for weight-for-
length/BMI-age percentiles and maternal smoking status (P =0.035, f = 4.601).   
Maternal smoking status was a self-report of whether the mother smoked before 
pregnancy (yes=33, no=39).  Some of the smokers reported not smoking during 
pregnancy (11 of 33).  Maternal pack years was an indicator of the amount and duration 
of smoking with a mean of 2.12 (SD=3.871) and range of 0 to 20 in the study population.  
Pack years were calculated by the number of packs per day (PPD) multiplied by the 
number of years smoked.  The observed power was 0.562.  Interaction between these 
terms was not significant.  Figure 3 shows weight-for-length/BMI-age percentiles across 
age broken out by maternal smoking status adjusted for maternal pack years.  It is evident 
that women who smoked, even those who stated they did not smoke during pregnancy, 
had infants/children with higher weight-for-length/BMI-age percentils than women who 





























FIGURE 3 Weight-for-length/BMI-age percentiles across age were separated by 
maternal smoking status prior to pregnancy adjusted for pack years (µ=2.12). 
 
We subsequently ran weight-for-age (weight-age) and length-for-age/height-for-
age (length/height-age) percentiles into age and maternal smoking status repeated 
measures ANOVAs adjusted for pack years.  Weight-age percentiles and maternal 
smoking status had marginal interaction (P =0.092) but no difference in main effects (P 
=0.831).  The observed power was 0.55.  Maternal smoking status did not have an effect 
on weight-age percentiles.   
Length/height-age percentiles and maternal smoking status had significant main 
effects (P =0.043) with no interaction across ages.  The observed power was 0.53.  
Mothers that smoked had children who were shorter.   
Also given that maternal smoking status was not associated with weight-age 




length/BMI-age percentile, it appears offspring of mothers that smoked were short r but 
had similar weight-age percentiles when compared to children whose mothers did not
smoke and put them in a higher weight-for-length/BMI-age percentile.  Illustrations of 
maternal smoking status and weight-age and length/height-age percentiles across age are 
found in Figures 4 and 5. 























FIGURE 4 Weight-age percentiles across age were separated by maternal smoking status 














FIGURE 5 Length/height-age percentiles across age were separated by maternal 




























   








Chapter 5: Discussion 
Currently research is sparse looking at the potential benefits of DHA 
supplementation through infant formula in relationship to BMI to four years of age.  
Although there is some evidence that DHA supplementation may affect growth in infancy 
and early childhood, there was no significant effect in our study population.  The number 
of subjects per formula group by 4 years of age was small (n = 16, 19, 17, 22).  The effect 
size of DHA on growth percentiles may have been too small to detect a difference with 
the number of subjects per group and power of 0.147.  After separating the formulas by 
DHA or no DHA (DHA group) there was still insufficient power (0.127) and it created 
uneven groups (n = 16, 58).   
Most studies of term infants that supplemented DHA through infant formula did 
not find a significant difference on weight-for-length during infancy compared to no 
supplementation (3, 63).  There was one study that found lower head circumference at 4 
months with formula containing 0.45% DHA and low-EPA fish oil compared to control 
formula without DHA (61).  Another study found significantly lower mean weight at 4 
months of age (P =0.055) with a high alpha-linolenic acid (ALA) supplemented formula 
(3.2% of fatty acids) (4).  There are no consistent physical growth differenc s during 
infancy with DHA supplementation compared to no DHA exposure though infant 
formula. 
Studies of BMI in young children show mixed results with maternal 
supplementation during pregnancy and/or lactation.  One study (n = 143) also found no 
significant effect of omega-3 supplementation on infant growth or on BMI at 4 years (7) 




larger head circumference at 2.5 years (9), and a third study (n = 69) found lower BMI at 
21 months.  Lauritzen et al. (9) supplemented mothers during lactation alone while the 
other trials supplemented women during pregnancy and lactation.  Exclusive post-natal 
supplementation is most similar to our study design; however, we fed infant formula not 
human milk.  Breast-fed infants grow differently than formula-fed infants but growth 
differences are not likely the result of any single nutrient (18, 19). 
The amount of DHA given to mothers varied between studies: 1200, 800, and 200 
mg DHA per day.  The study with the highest dose (1200 mg/day) had no effect, while 
the group supplementing only 200 mg per day found lower BMI in toddlers.  The fish 
consumption in the regions where the studies were conducted (Germany, Norway, and 
Denmark) varies considerably, so baseline dietary DHA was inconsistent between 
studies.   In the study from Norway researchers excluded mothers with high fis  intake 
and used a larger dose of DHA (1200 mg) compared to the other trials and still found no 
effect on growth to 7 years of age.  Our study was conducted in the United Sta s where 
DHA intake is relatively low (48) and did not find a difference in growth percentiles 
between groups supplemented with varying levels of DHA in infant formula. 
Arachidonic acid (ARA) is an omega-6 fatty acid that has shown lower growth 
indices when absent from infant formula (51).  There was no ARA in the control formula 
while there was consistent ARA in the three formulas that contained DHA.  The effect of 
ARA on growth is not fully understood and could have counteracted the effect of DHA in 







There are certainly many contributing factors to growth in infancy and early 
childhood that affect weight-for-length and BMI.  It is possible that other factors 
overpowered the effect of DHA consumed during the first 12 months of age.  Some 
factors include the introduction of various foods and the quality of the diet during and 
after weaning from formula.  Additionally, the amount of formula and food consumed 
has an impact on weight.   
We obtained very careful dietary recalls; however, the calorie intakes obtained 
were estimates from parent(s) or caregiver(s) and may have contained some 
overestimation of calories.  There is evidence that when obtaining 24-hour recalls for 
infant and toddler energy intake, parents and caregivers often overestimate due to portion 
size error (65).  Our calorie intake data were fairly consistent between formula groups as 
shown in Table 4.  The energy intakes were all significantly higher than the Dietary 
Reference Intakes (DRIs) for energy in infants and children; however, we cannot say if or 
to what degree there was overestimation. 
 The Center for Disease Control (CDC) growth percentiles changed from weight-
for-length to BMI-age at two years of age.  The BMI-age percentiles are lower than 
weight-for-length percentiles and caused a dip in the growth trajectories f all ormula 
groups.  The World Health Organization (WHO) has growth percentiles that include 
BMI-age starting at birth and continuing through adulthood.  Although there would be 
consistency from birth to four years, the WHO percentiles are not representativ  of our 
population.  The WHO percentiles were developed from the Multicenter Growth 




Norway, Oman, and the USA).  The data represents breast-fed infants with broadly 
different ethnic backgrounds.  Breast-fed infants grow differently than formula-fed 
infants and the diverse ethnicity of the WHO percentiles is not representative of our study 
population.   
 Exploratory Data 
This study found that maternal age is positively related to the size of infant at 
birth and 6 weeks of age.  In our population younger mothers gave birth to smaller infnts
while older mothers birthed larger infants.  The mean age of mothers at delivery was 23.4 
with a range of 16 to 35 years of age.  Research suggests that socioeconomic fact rs, 
poverty, limited education, underutilization of prenatal care, and race/ethnicity may 
explain the effect of young maternal age on pregnancy outcomes such as low birth weight 
(66). Although our study did not include low birth weight infants, younger mothers had 
smaller babies than older mothers.   
Our study supports other research findings that mother’s weight is related to 
child’s BMI (67, 68).  Although a large body of research has assessed direct genetic links 
between parent and child weight status, relatively little research has asse sed the extent to 
which parents, particularly those who are overweight, select environments that promote 
overweight among their child/children; more research is needed to develop and test 
theoretical models describing how a wide range of environmental and behavioral factors
impact childhood obesity (69).   Our study showed a correlation between maternal weight 
and child weight-for-length/BMI-age percentile starting at 18 months of age and 




This study also has large implications concerning the rise of overweight and 
obesity in children as young as two years of age.  Our population had an alarming 
increase in BMI-age percentile from 2 to 4 years of age with 39% overweight or obese 
(≥85th percentile) at 4 years of age and of those 14.3% were obese (≥95th percentile).  The 
obesity rate is similar to a 2008 report of 14.6% prevalence of childhood obesity in low-
income preschool aged children from CDC's Pediatric Nutrition Surveillance Syst m 
(PedNSS) (70).  
Further observation of these children’s BMI-age percentiles would be valuable to 
monitor whether the rapid increase in BMI-age percentile continues or if it plateaus 
during older years.  Additionally, further research on the prevalence of overweight and 
obesity starting in toddlerhood is appropriate given these findings and with the recent rise 
in overweight status in children in the United States (31, 70).   
Maternal Smoking and Infant Growth 
Smoking during pregnancy is associated with a higher rate of small-for-
gestational-age (SGA) and low birth weight (LBW) infants (71, 72).  Additionally, high 
smoke exposure has a modest association with low birth weight (72).  One mechanism 
behind intrauterine exposure to tobacco smoke and small-for-gestational-age (SGA) and 
low birth weight (LBW) is accumulation of toxins such as cadmium in the maternal 
placenta.   The build-up of cadmium reduces the transport of micronutrients such as zinc 
to the growing fetus (73).   
Although our infants’ mean birth weight was near the 50th percentile, mothers 
who smoked before or during pregnancy had infants that were shorter and had higher 




explain higher weight-for-length in infants and BMI in children whose mothers smoked 
and birthed smaller infants.  Figure 4 illustrates that the mean weight percentile of infants 
born to smokers was lower at birth than the mean weight percentile of infants born to 
nonsmokers but they come together by 6 weeks of age; however, this difference is not 
statistically significant.  It appears that infants experienced ample catch-up in weight but 
not in height as illustrated in Figure 5.   
As discussed in Chapter 2, rapid weight gain in infancy leads to an increased risk 
of overweight status in early childhood.  Our study population has an alarming number of 
children at or above the 85th percentiles by 4 years of age and maternal smoking may be a 
contributing factor to shorter stature and higher BMI.   
Another study conducted at the University of Kansas Medical Center found 
maternal smoking was associated with an increased risk of late onset overweight but not 
early onset overweight (occurring before 2 years of age).  In our study populati n, it 
appears infants whose mothers smoked were more likely to be overweight early (6 weeks 
and older) but do not become more overweight with time as illustrated in Figure 4.  
Infants whose mothers did not smoke had a lower BMI than those whose mothers did 
smoke in the first two years of life, however, their BMIs eventually caught p to the BMI 
of children born to smokers.  Further studies are warranted to understand the impact of 
maternal smoking and/or smoke exposure during pregnancy and the long term 







Chapter 6: Summary 
Docosahexaenoic acid (DHA) is an omega-3 fatty acid essential for brain growth 
and cognitive development in infancy.  It is currently supplemented in infant formulas in 
the United States.  There is some evidence that DHA can also influence growthin infancy 
and early childhood.  Several clinical trials with infants and young children have found 
lower normalized growth following DHA increased exposure through maternal 
supplementation during pregnancy and/or lactation or infant formula supplementation.   
The aim of this study was to evaluate the impact of feeding one of four 
concentrations of DHA in infant formula on weight-for-length percentile (<2 years) and 
body mass index percentile (≥2 years) at twelve ages from birth to four years of age.  
Healthy formula-fed infants were randomized to one of four infant formulas containing 0, 
0.32, 0.64, or 0.96% of total fatty acid from DHA.    Maternal physical and demographic 
characteristics such as age, height, weight at delivery, highest level of education, and 
smoking status before and during pregnancy were recorded at the beginning of the study.  
Weight, length, and head circumference of the infant were measured at 6 weeks, 4 
months, 6 months, 9 months, 12 months, 18 months, 2 years, 2.5 years, 3 years, 3.5 years, 
and 4 years of age.  Subjects were normalized to the Center for Disease Control weight-
for-length (<2 years) and BMI-age growth charts (≥2 years) by calculating percentiles.  
Trained study personnel obtained 24-hour dietary recalls of the infant or child intake at 
each of the study visits and they were analyzed in NDSR. 
Two-tailed Pearson correlations for maternal weight and age at delivery, height, 
as well as maternal pack years prior to pregnancy, highest attained education level, and 




months, 9 months, 1 year, 1.5 years, 2 years, 2.5 years, 3 years, 3.5 years and at 4 years) 
were obtained by using SPSS.  There were no significant correlations between mat r al 
height or education level and weight-for-length/BMI-age percentile at any age.  Maternal 
smoking in pack years was negatively associated with birth weight-for-length percentile 
(P <  0.05).  Maternal age at delivery was positively associated with birth (P < 0 .01) and 
6 week (P < 0.05) weight-for-length percentile.  Maternal weight in pounds at delivery 
was positively associated with weight-for-length percentile at 18 months and BMI-age 
percentile at 3, 3.5, and 4 years of age (P < 0.05).   
The relationship between weight-for-length/BMI-age and concentrations in the
study formula was evaluated with a two way repeated measures ANOVA across age 
using a p-value of 0.05 as statistically significant.  Then infants were separated by DHA 
or no DHA and we ran a similar repeated measures ANOVA for weight-for-length and 
BMI-age percentiles across study visits and DHA status (DHA supplementation versus 
no DHA supplementation) using a p-value of 0.05.   
The concentration of DHA consumed through infant formula during the first year 
of life did not impact weight-for-length or BMI-age percentile from birth to 4 years of 
age (P =0.683)  The number of subjects per group was 16,19,17, and 22; the observed 
power was low (.147) .  When grouped by DHA or no DHA (n = 16, 58) there was no 
statistical significance (P =0.416) and low observed power (0.127).  There is no 
observable difference in weight-for-length or BMI-age in infants supplemented DHA 
through infant formula in the first four years of life.   
As a result of finding a significant negative association between maternal pack 




percentage of mothers who smoked and growth data of offspring to 4 years of age we 
explored maternal smoking status and growth.  A repeated measures ANOVA with 
weight-for-length/BMI-age percentiles entered into age (12) and maternal smoking status 
(2) with maternal pack years as a covariate had significant main effects for age and 
maternal smoking status (P =0.035, f=4.601).   
We subsequently ran weight-age and length/height-age percentiles into age and 
maternal smoking status repeated measures ANOVAs adjusted for pack years.  Weight-
age percentiles and maternal smoking status had marginal interaction (P =0.092) but no 
difference in main effects (P =0.831).  The observed power was 0.55.  Material smoking 
status did not have an effect on weight-age percentiles.  Length/height-age percentiles 
and maternal smoking status had significant main effects (P =0.043) with no interaction 
across ages.  The observed power was 0.53.  Mothers that smoked had infants/children 
who were shorter and had higher weight-for-length/BMI-age percentiles compared to 
infants birthed from nonsmoking mothers. Further studies are warranted to understand the 
impact of maternal smoking and/or smoke exposure during pregnancy and the long term 
implications on stature and weight in the offspring. 
Our study population had an alarming increase in BMI-age percentile from 2 t 4
years of age with 39% overweight or obese (≥85th percentile) at 4 years of age and of 
those 14.3% were obese (≥95th percentile).  Further observation of these children’s BMI-
age percentiles would be valuable to monitor whether the rapid increase in BMI-age 
percentile continues or if it plateaus during older years.  Further research on the 
prevalence of obesity starting in the toddler years is appropriate given these findings and 
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#10205       
           
DEMOGRAPHICS 
           
Maternal 
Education         
           
Paternal 
Education         
           
Does anyone living in the child's home smoke?      
  No  Yes 
 If yes, how many people smoke & how many ppd?  
__________________ 
List any maternal allergies: 
_________________________________________________________________ 
Including the child enrolled in this study, how many children 13 years of age or younger live in your 
house? 
 1    2    3    4    5    6 or more 
Do any pets live in the child's home?       
  No  Yes   If yes, how many pets?  __________________________ 
    
  What kind? 
________________________________________________ 
Do you take your child to a daycare (facility or homecare) with other infants and children? 
  No         
  Yes, with 1 to 5 children       
  Yes, with 6 to 10 children       































 2 Year Visit  Weight     g  
           
        Length     cm 
 MO DA YEAR         
     Head circumference    cm 
                      
           
 2.5 Year Visit  Weight     g  
           
        Length     cm 
 MO DA YEAR         
     Head circumference    cm 
                      
           
 3 Year Visit  Weight     g  
           
        Length     cm 
 MO DA YEAR         
     Head circumference    cm 
                      
           
 3.5 Year Visit  Weight     g  
           
        Length     cm 
 MO DA YEAR         
     Head circumference    cm 
                      
           
 4 Year Visit  Weight     g  
           
        Length     cm 
 MO DA YEAR         
     Head circumference    cm 
                      
           
 INVESTIGATOR PROTOCOL  INITIALS  RANDOM CODE  DOB 
 CARLSON HSC #10205          










ANTHROPOMETRICS PAGE 2 
           
 4.5 Year Visit  Weight     g  
           
        Length     cm 
 MO DA YEAR         
     Head circumference    cm 
                      
           
 5 Year Visit  Weight     g  
           
        Length     cm 
 MO DA YEAR         
     Head circumference    cm 
                      
           
 5.5 Year Visit  Weight     g  
           
        Length     cm 
 MO DA YEAR         
     Head circumference    cm 
                      
           
 6 Year Visit  Weight     g  
           
        Length     cm 
 MO DA YEAR         
     Head circumference    cm 




























24-Hour Dietary Recall Form 
Visit:_________         
          
Random 
#___________________ 
   Date of 
Intake:____________ DOB:___________ EDC:__________ 
          
Time Food/Beverage Ingredients/Preparation Amount 
                    
                    
                    
                    
                    
                    
                    
                    
                    
                    
                    
                    
                    
                    
                    
                    
                    
                    
                    
          
Intake: Typical      More than Usual          Less than Usual         Why? _______________________________ 
_________________________________________________________________________________________ 
Recall:  Reliable     Unable to recall meals?  Unreliable for other reasons?  Why? _______________________ 
_________________________________________________________________________________________ 
          
Vitamin/Mineral/Supplement Use?  __________________________________________________________ 
          
Home / Daycare / Babysitter                          Number of people responsible for feeding _______________ 
          


























Unable to recall one or more meals: 21 total 
Subject 5 at 2 years (at school) 
Subject 9 at 2.5, 3, and 4 years (primary caregiver at work) 
Subject 24 at 2 (daycare) and 2.5 years (mom at work, dad brought child to appointment) 
Subject 34 at 2 years (with grandma) 
Subject 35 at 2 years (daycare) 
Subject 39 at 6 months (with grandma) and 2.5 years (unable to recall dinner, not at home) 
Subject 46 at 3.5 years (daycare) 
Subject 50 at 6 months (with babysitter) 
Subject 62 at 2 years (with dad for dinner) 
Subject 84 at 3.5 years (daycare) 
Subject 89 at 18 months (no amounts specified) 
Subject 97 at 4 years (daycare) 
Subject 102 at 18 months, 2 years, and 4 years (missing meals, daycare) 
Subject 113 at 3.5 years (snacked all day, couldn’t recall all eating occasions) 
Subject 154 at 4 years (daycare) 
 
Over reporting (>200 kcals/kg): 23 total  
Subject 4 at 18 months 
Subject 9 at 6 weeks  
Subject 17 at 9 months 
Subject 19 at 18 months 
Subject 30 at 2 years 
Subject 59 at 12 months 
Subject 85 at 6 weeks 
Subject 86 at 6 weeks 
Subject 88 at 2 years 
Subject 95 at 12 months 
Subject 97 at 2.5 years 
Subject 98 at 18 months 
Subject 101 at 6 weeks and 9 months 
Subject 103 at 4 years 
Subject 108 at 2.5 years 
Subject 114 at 6 weeks 
Subject 120 at 18 months and 2 years 
Subject 121 at 18 months 
Subject 125 at 6 weeks 
Subject 140 at 6 weeks 
Subject 149 at 6 months 
 
Under reporting (<40 kcals/kg): 6 total 
Subject 46 at 4 years 
Subject 54 at 9 months 
Subject 62 at 18 months 
Subject 82 at 6 weeks 
Subject 87 at 18 months 














































































Parent Study Consent Form 2 to 6 Years of Age 
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